FDA says some CBD oil recalled across US over risk of lead poisoning

A batch of CBD oil that was distributed nationwide in the US has been recalled after it tested positive for high levels of lead. The FDA warns that consuming this CBD oil could potentially result in lead poisoning, a serious condition that could, among other things, result in kidney damage and shock. There haven’t been any consumer complaints related to the CBD, however.

The voluntary recall comes from Summit Labs for its Kore Organic CBD oil, specifically a batch of watermelon-flavored tincture from which a sample tested with 4.7ppm of lead. The high lead sample came from the recalled Batch #730 Lot#K018, which contained 30ml bottles of 15mg 450x products sold to consumers.

The high level was detected in a random sample tested by the Florida Department of Agriculture and Consumer Service. Summit Labs reports that it tested a sample from the same batch and found that the lead levels were within the legal limits at 0.5ppm. Despite that, the entire batch has been recalled based on the sample that tested with high levels.


Leave a Reply